Thornburg Income Builder Opportunities Trust (NASDAQ:TBLD – Get Free Report) announced a monthly dividend on Monday, July 1st, investing.com reports. Shareholders of record on Thursday, July 11th will be given a dividend of 0.1042 per share on Friday, July 19th. This represents a $1.25 dividend on an annualized basis and a yield of 7.55%. The ex-dividend date of this dividend is Thursday, July 11th.
Thornburg Income Builder Opportunities Trust Stock Up 0.3 %
TBLD stock opened at $16.55 on Wednesday. Thornburg Income Builder Opportunities Trust has a one year low of $13.44 and a one year high of $16.71. The firm has a 50-day moving average of $16.01 and a two-hundred day moving average of $15.83.
Insider Transactions at Thornburg Income Builder Opportunities Trust
In related news, insider Brian W. Wixted purchased 1,620 shares of Thornburg Income Builder Opportunities Trust stock in a transaction dated Tuesday, April 23rd. The stock was acquired at an average cost of $15.50 per share, with a total value of $25,110.00. Following the completion of the transaction, the insider now directly owns 1,620 shares of the company’s stock, valued at $25,110. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Thornburg Income Builder Opportunities Trust Company Profile
The Trust is a global, multi-asset, actively managed portfolio that seeks to generate an attractive income stream by providing investors differentiated access to a dynamic blend of income generating investments. Thornburg believes that markets are inefficient with respect to the assessment of risk and reward due to the siloed nature of multi-asset analysis.
Featured Stories
- Five stocks we like better than Thornburg Income Builder Opportunities Trust
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Top 2 Cybersecurity Stocks Booming in an Age of Rising Threats
- How to Use the MarketBeat Dividend Calculator
- Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
- The Role Economic Reports Play in a Successful Investment Strategy
- Uncover Why This Pharma Stock Jumped 400% on Study Update
Receive News & Ratings for Thornburg Income Builder Opportunities Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thornburg Income Builder Opportunities Trust and related companies with MarketBeat.com's FREE daily email newsletter.